About the PMPRB

The PMPRB protects and informs Canadians by ensuring that the prices of patented medicines sold in Canada are not excessive and by reporting on pharmaceutical trends.

CompassRx, 5th Edition

Annual Public Drug Plan Expenditure Report, 2017/18

Find out more…

Amendments to the Patented Medicines Regulations - Questions and Answers

Health Canada announced amendments to the Patented Medicines Regulations in Canada Gazette, Part II on August 9, 2019. The following questions and answers address concerns and questions that Canadians and stakeholders may have.

Find out more…

Generics360

Generics360 – Generic Drugs in Canada, 2018

Generics360 reports on the latest trends in the Canadian generic drug market within an international context. Canada has established one of the strongest generic markets in the industrialized world, though domestic prices have historically been much higher than international levels.

Find out more…

CompassRx 4

Meds Pipeline Monitor 2018

This horizon scanning report highlights potential new medicines worth watching.

Find out more…

SteeringCommittee

The PMPRB is consulting with its stakeholders on changes to its non-binding guidelines (the “Guidelines”), as contemplated by subsection 96(4) of the Patent Act.

Find out more

I am a/an...

Consumer

Patentee

Other Stakeholder

Features

Annual Report 2017

Annual Report

PMPRB NEWSletter

Analytical Studies

Date modified: